Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. 2014

Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

BACKGROUND Abnormal intrathecal synthesis of IgG, reflected by cerebrospinal fluid (CSF) oligoclonal IgG bands (OBs) and increased IgG index, is much less frequently observed in Japanese multiple sclerosis (MS) cohorts compared with Western cohorts. We aimed to clarify whether genetic and common infectious backgrounds influence CSF IgG abnormality in Japanese MS patients. METHODS We analyzed HLA-DRB1 alleles, and IgG antibodies against Chlamydia pneumoniae, Helicobacter pylori, Epstein-Barr virus nuclear antigen (EBNA), and varicella zoster virus (VZV) in 94 patients with MS and 367 unrelated healthy controls (HCs). We defined CSF IgG abnormality as the presence of CSF OBs and/or increased IgG index (>0.658). RESULTS CSF IgG abnormality was found in 59 of 94 (62.8%) MS patients. CSF IgG abnormality-positive patients had a significantly higher frequency of brain MRI lesions meeting the Barkhof criteria compared with abnormality-negative patients. Compared with HCs, CSF IgG abnormality-positive MS patients showed a significantly higher frequency of DRB1 1501, whereas CSF IgG abnormality-negative patients had a significantly higher frequency of DRB1 0405. CSF IgG abnormality-positive MS patients had a significantly higher frequency of anti-C. pneumoniae IgG antibodies compared with CSF IgG abnormality-negative MS patients, although there was no difference in the frequency of anti-C. pneumoniae IgG antibodies between HCs and total MS patients. Compared with HCs, anti-H. pylori IgG antibodies were detected significantly less frequently in the total MS patients, especially in CSF IgG abnormality-negative MS patients. The frequencies of antibodies against EBNA and VZV did not differ significantly among the groups. CONCLUSIONS CSF IgG abnormality is associated with Western MS-like brain MRI features. DRB1 1501 and C. pneumoniae infection confer CSF IgG abnormality, while DRB1 0405 and H. pylori infection are positively and negatively associated with CSF IgG abnormality-negative MS, respectively, suggesting that genetic and environmental factors differentially contribute to MS susceptibility according to the CSF IgG abnormality status.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004777 Environment The external elements and conditions which surround, influence, and affect the life and development of an organism or population. Environmental Impact,Environmental Impacts,Impact, Environmental,Impacts, Environmental,Environments
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus

Related Publications

Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
September 1993, Acta neurologica Scandinavica,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
May 2007, Acta neurologica Scandinavica,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
January 2011, Multiple sclerosis international,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
January 1989, Schriftenreihe Neurologie,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
February 1976, The New England journal of medicine,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
January 1988, Annals of the New York Academy of Sciences,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
January 1979, Acta neurologica Scandinavica,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
October 1974, British medical journal,
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
August 2004, Multiple sclerosis (Houndmills, Basingstoke, England),
Satoshi Yoshimura, and Noriko Isobe, and Takuya Matsushita, and Katsuhisa Masaki, and Shinya Sato, and Yuji Kawano, and Hirofumi Ochi, and Jun-Ichi Kira
December 1990, Journal of neuroimmunology,
Copied contents to your clipboard!